Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 30 years old or older
- You identify yourself as African American, OR you have a parent, child, or sibling who has been diagnosed with a blood-related condition such as MGUS, SMM, multiple myeloma, Waldenström's Macroglobulinemia, or another blood cancer
- If you are between 18 and 29 years old, you may still be eligible if two or more of your family members have been diagnosed with a blood cancer
- Special populations including pregnant women, prisoners, and adults who are unable to give consent on their own may still be eligible, as this is a non-treatment study (confirm with trial site)
Who may not be able to join:
- You have been diagnosed with any type of cancer that is currently causing symptoms and requires active treatment
- You have already been diagnosed with a plasma cell condition such as MGUS, SMM, multiple myeloma, or Waldenström's Macroglobulinemia
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Irene Ghobrial, MD, Dana-Farber Cancer Institute
Phone: 617-632-4198
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to progression (TTP) from MGUS/SMM to overt multiple myeloma.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.